FORT WORTH, TX, Ọgọst 2, 2022 (GLOBE NEWSWIRE) - TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) bụ ụlọ ọrụ na-ahụ maka ahụike biopharmaceutical ụlọ ọrụ ọkachamara na Thin Film Refrigeration (TFF) teknụzụ teknụzụ maka mmepe na ịzụ ahịa nke ngwaahịa ọgwụ ọhụrụ. , taa mara ọkwa na ọ ga-ahapụ ya nke abụọ nkeji iri na ise 2022 ego nsonaazụ ego na azụmahịa nyochaa na Thursday.Ọgọst 11, 2022, na njedebe nke ahịa ego US.
Nlekọta ga-ejide oku ogbako na 4: 30 pm ET iji kparịta nsonaazụ ego ma nye mmelite maka mmepe ụlọ ọrụ na ụlọ ọgwụ.Ngosipụta a ga-esochi nnọkọ Q&A na ndị investors.
Ụlọ ọrụ ahụ ga-enwe oku ogbako na Thursday, August 11, 2022 na 4: 30 pm ET iji nyochaa ụlọ ọgwụ, ụlọ ọrụ na ọrụ ego.Iji sonye ogbako a, sonye na webcast ma ọ bụ pịa otu n'ime ihe ndị a tupu ịmalite oku:
Oku a ga-adịkwa ndụ wee nwee ike ịnweta ya na weebụsaịtị TFF Pharmaceuticals, https://tffpharma.com ma ọ bụ ozugbo na https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Oku a ga-adịkwa ndụ wee nwee ike ịnweta ya na weebụsaịtị TFF Pharmaceuticals, https://tffpharma.com ma ọ bụ ozugbo na https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Конференция также будет TRANSILYROваться в прямом эфире и доступна на веб-сйте TFF Pharmaceuticals https://tffpharma.com . casts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. A ga-agbasakwa ogbako a na ndụ ma dị na weebụsaịtị TFF Pharmaceuticals https://tffpharma.com ma ọ bụ ozugbo na https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47.电话会议还将进行网络直播，可以在TFF Pharmaceuticals 的网站https://tffpharma.com 3b9453c47 访问. TFF Pharmaceuticals 的网站https://tffpharma.com 或直接访问https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key34=43 Конференц-связь также будет транслироваться в Интернете и доступна на веб-сайте TFF ọgwụ pharmaceuticals Ebe https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47. Oku ogbako a ga-abụkwa webụsaịtị wee dị na webụsaịtị TFF Pharmaceuticals na https://tffpharma.com ma ọ bụ ozugbo na https://viavid.webcasts.com/starthere.jsp?ei=1558913&tp_key=43b9453c47.Biko gaa na webụsaịtị ụlọ ọrụ ahụ opekata mpe nkeji iri na ise tupu oge ịdebanye aha, budata na wụnye ngwanrọ ọdịyo niile achọrọ.A ga-akpọkwa oku a n'ime ọnwa niile na ngalaba Kalịnda Investor nke webụsaịtị ụlọ ọrụ ahụ.
Banyere TFF PHARMACEUTICALS Thin Film Freezing Technology Platform TFF Pharmaceuticals 'technology Thin Film Freezing (TFF) na-enye ohere ka a gbanwee ogige ndị dị ugbu a na kemịkalụ ọhụrụ ka ọ bụrụ usoro ntụ ntụ akọrọ nwere ihe pụrụ iche na uru.The film kefriza usoro bụ urughuru engineering usoro e mere na-emepụta akọrọ ntụ irighiri irighiri na mma Njirimara maka ikuku ume, parenteral, imi, ọnụ, Topical na ophthalmic ụzọ nlekọta.Enwere ike iji usoro a mepụta powders maka nnyefe ozugbo na saịtị a chọrọ, si otú a na-ezere nsogbu nchịkwa usoro na imeziwanye bioavailability, ngwa ngwa ngwa ngwa, na imeziwanye nchekwa na ịdị irè.Ikike nke ịnye ọgwụgwọ ozugbo na akụkụ ndị e lekwasịrị anya dị ka ngụgụ na-enye ohere ka a na-enye ntụ ntụ TFF na obere doses ma e jiri ya tụnyere usoro ọnụ, na-ebelata nsị na-enweghị isi na mmetụta.Data ụlọ nyocha na-egosi na akụrụngwa ikuku nke ntụ ntụ oyi kpọnwụrụ akpọnwụ nwere ike ibunye ihe ruru 75% nke ọgwụ n'ime ngụgụ.Kama ikpughe na ikpo ọkụ, nrụgide siri ike, ma ọ bụ ike ndị ọzọ nwere ike imebi ihe ndị dị mgbagwoju anya nke ọgwụgwọ dị ka ihe ndị dị ndụ na-esighị ike, ihe nkiri na-egbuke egbuke na-eme ka ihe ndị a gbanwee ghọọ ntụ ntụ nke dị mfe ịchekwa na okpomọkụ dị jụụ, na-enye ohere ọgwụgwọ na ọgwụ mgbochi. a ga-ekesa karịa n'ụwa niile..Enwere ike iji uru dị na friza ihe nkiri dị mkpa iji meziwanye nnyefe ọdịnala ma ọ bụ jikọtara ya na ọgwụ ọgbọ na-abịa.
Banyere TFF PHARMACEUTICALS TFF Pharmaceuticals, Inc. bụ ụlọ ọrụ ahụike biopharmaceutical ụlọ ọrụ nke na-eji teknụzụ ifriizi ngwa ngwa emebere patent iji mepụta ma gbanwee ọgwụ n'ime usoro ntụ ntụ dị irè iji meziwanye nrụpụta, nchekwa na nkwụsi ike.Ngwá ọrụ teknụzụ dị iche iche nke Thin Film Freezing (TFF) nke ụlọ ọrụ ahụ nwere ngwa ngwa na-atụgharị ọgwụ ọ bụla, gụnyere ịgba ọgwụ mgbochi ọrịa, obere ụmụ irighiri ihe na ihe ndị dị ndụ, n'ime ntụ ntụ akọrọ mara mma nke dị mfe iku ume na nke ọma, ya mere ọgwụ ahụ nwekwara ike ịbụ. nyefere.na anya, imi na mpaghara akpụkpọ.TFF nwere ndị na-achọ ọgwụ ọgwụ abụọ bụ isi, voriconazole inhalation powder na tacrolimus inhalation powder, ma na-aga n'ihu na-agbasawanye Pọtụfoliyo ya iji gbanwee nlekọta ahụike zuru ụwa ọnụ site na imekọ ihe ọnụ na ụlọ ọrụ ọgwụ dịgasị iche iche, ụlọ ọrụ agụmakwụkwọ na ndị mmekọ gọọmentị.Ihe karịrị patent 120 enyere ma ọ bụ na-echere na US na obodo ndị ọzọ kpuchie ikpo okwu TFF.Iji mụtakwuo maka TFF Pharmaceuticals na ngwaahịa ndị a ga-azọ ọkwa ya, biko gaa na webụsaịtị ụlọ ọrụ na https://tffpharma.com.
Ebe nchekwa nchekwa akwụkwọ akụkọ a nwere nkwupụta na-atụ anya banyere TFF Pharmaceuticals, Inc., gụnyere atụmanya ya maka mmepe mmepe nke tacrolimus na voriconazole inhaled powders, uru nke ikpo okwu TFF nke ụlọ ọrụ ahụ, yana atụmatụ ụlọ ọrụ ịgbakwunye n'ahịrị ngwaahịa nke nwa akwukwo ya dị adị. .Okwu ndị a na-atụ anya n'ihu gụnyere ihe egwu ama ama na amaghị ama, ejighị n'aka na ihe ndị ọzọ nwere ike ime ka nsonaazụ n'ezie dị iche n'anụ ahụ.Ihe ndị a gụnyere: (i) ihe ize ndụ na ụlọ ọrụ ahụ agaghị enwe ike imezu ule ụlọ ọgwụ nke ọma ma ọ bụ nweta nkwenye premarket maka tacrolimus inhaled ya, voriconazole ntụ ntụ, ma ọ bụ nke ọ bụla n'ime ndị na-eme ntụ ntụ akọrọ, (ii) enweghị ndepụta nke ihe ndị ahụ. ọgwụ n'elu ikpo okwu TFF enwetala FDA tupu nkwado ma ọ bụ depụta ọgwụ azụmahịa, (iii) ụlọ ọrụ ahụ enweghị nkwekọrịta ma ọ bụ nghọta ugbu a na ụlọ ọrụ ọgwụ ọ bụla iji mepụta ọgwụ maka ntinye na ikpo okwu TFF, (iv) na ụlọ ọrụ agaghị enwe ike ịbanye na nkwekọrịta azụmahịa ogologo oge na ndị ọzọ ọ bụla;na (v) ihe egwu ndị ọzọ achọpụtara na ngalaba “Ihe ize ndụ” nke ụdị 10 nke ụlọ ọrụ 2021 Annual Report – K, gbara akwụkwọ na SEC na Maachị 24, 2022. TFF Pharmaceuticals na-adọ ndị na-agụ akwụkwọ aka na ntị ka ha ghara itinye ntụkwasị obi na-ekwesịghị ekwesị na onye ọ bụla ma ọ bụ gaa n'ihu. na-ekwu okwu.TFF Pharmaceuticals na-ewere ma kwupụta kpọmkwem ọrụ ọ bụla imelite ma ọ bụ megharịa nkwupụta dị otú ahụ iji gosipụta ọnọdụ ọhụrụ ma ọ bụ ọnọdụ a na-atụghị anya ya, belụsọ dị ka iwu chọrọ.
TFF Pharmaceuticals Investor Relations Contact: Corey Davis, PhD LifeSci Advisorsscdavis@lifesciadvisors.com 212-915-2577
TFF Pharmaceuticals Media Contact: Gwendolyn SchankerLifeSci Communications(269) 921-3607gschanker@lifescicomms.com
Oge nzipu: Ọgọst-10-2022